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Abstract
Background: Recent studies using sheep critical sized defect models to test tissue engineered products report
high morbidity and complications rates. This study evaluates a large bone defect model in the sheep tibia,
stabilized with two, a novel Carbon fibre Poly-ether-ether-ketone (CF-PEEK) and a locking compression plate (LCP)
which could sustain duration for up to 6 month with an acceptable low complication rate.
Methods: A large bone defect of 3 cm was performed in the mid diaphysis of the right tibia in 33 sheep. The
defect was stabilised with the CF - PEEK plate and an LCP. All sheep were supported with slings for 8 weeks after
surgery. The study was carried out for 3 months in 6 and for 6 months in 27 animals.
Results: The surgical procedure could easily be performed in all sheep and continuous in vivo radiographic
evaluation of the defect was possible. This long bone critical sized defect model shows with 6.1% a low rate of
complications compared with numbers mentioned in the literature.
Conclusions: This experimental animal model could serve as a standard model in comparative research. A well
defined standard model would reduce the number of experimental animals needed in future studies and would
therefore add to ethical considerations.
Background
The healing of large bone defects caused by tumour, infec-
tion or high energy trauma remains one of the most chal-
lenging orthopaedic problems for both surgeons and
patients. Autologous bone transplantation using cancel-
lous bone graft harvested from sites such as the iliac crest,
is currently considered as “gold standard” for reconstruc-
tion of these defects [1,2]. The process of harvesting the
cancellous bone, however, is associated with a high rate of
donor site morbidity, and an increased risk of infection,
nerve damage and loss of function [3]. Furthermore, the
amount of suitable bone can be limited, particularly in
older patients. Tissue engineering offers a possible solution
to the problems of autologous bone transplantation.
Tissue engineered constructs employ a combination of
biodegradable, osteoconductive scaffolds, cells that provide
osteogenic potential and osteoinductive growth factors
[4,5]. Comprehensive evaluation of new tissue engineered
constructs requires both in vitro and in vivo testing. In
vitro testing is popular for the characterisation of tissue
engineered constructs particularly as medical researchers
embrace the principles of animal reduction. In vitro testing
gives useful information regarding cytotoxicity, genotoxi-
city, cell proliferation and differentiation [6,7] and is parti-
cularly useful for the screening of new materials [8]. The
final stages of evaluation prior to use in humans, however,
requires in vivo testing in an animal model in order to
demonstrate the tissue response to the construct. Critical
sized defect models that simulate the poor healing seen in
human patients with large bone defects have been devel-
oped in a number of species including rodents, rabbits,
pigs, goats, dogs and sheep [9,10]. The sheep critical sized
defect model offers some unique advantages over other
species that makes it particularly feasible for modelling
human orthopaedic disease. Adult sheep are similar in
body weight to humans and have long bones with similar
surface to volume ratios and remodelling properties to
humans. Therefore, the biomechanical and bone healing
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any medium, provided the original work is properly cited.characteristics of sheep are more similar to those found in
humans than of other, smaller species [9]. Furthermore,
sheep are easy to handle, inexpensive to keep, and are not
considered companion animals, which improves their ethi-
cal acceptability. A number of studies using sheep critical
sized defect models report high morbidity and complica-
tion rates that range from 2.5% [11] up to 33% [12]. These
studies vary in their experimental design, surgical techni-
que and defect stabilisation technique, which makes com-
parison between these studies difficult. For this reason and
after experiencing high complication rates in previous
experiments in our institute we have designed a critical
sized defect model in the sheep using two plates that
enables in vivo radiographic monitoring of bone healing
while overcoming the problems of high morbidity and
high complication rates. Therefore, we set out to test the
hypothesis that a 3 cm, critical sized defect in the sheep
tibia stabilized with two, a novel Carbon fibre Poly-ether-
ether-ketone (CF-PEEK) and a locking compression plate
(LCP), can sustain a duration of up to 6 month and allows
in vivo monitoring of bone healing.
Methods
Experimental animals
Thirty-three, skeletally mature, Swiss alpine sheep were
selected for the study. The mean weight of the sheep was
62.6 kg (range: 50.0 to 78.0 kg). A pre-operative physical
examination revealed no gross abnormalities in any of the
sheep. Pre-operative radiographs which were used to con-
firm skeletal maturity based on closure of the tibial physis,
revealed no bony abnormalities of both tibiae. Six sheep
were maintained post-operatively for duration of 3 months
and 27 sheep were maintained for duration of 6 months.
Following surgery, sheep were housed in single stalls, fed a
maintenance ration of hay and had ad libitum access to
water for the whole duration of the study. All procedures
during the study were carried out according to the Swiss
Laws of animal welfare and were approved by the local
Ethics Commission of the official veterinary authorities
(Authorisation Number: 10/2005).
Surgical Procedure
All surgical procedures were performed under general
anaesthesia. General anaesthesia was induced with butor-
phanol (0.06 mg/kg BW intravenously (iv), Morphasol,
Gräub AG, Bern, Switzerland), midazolam (0.3 mg/kg BW
iv, Dormicum, Roche Pharma, Reinach, Switzerland) and
thiopental (5-10 mg/kg BW iv to effect, Pentothal, Abbott
AG, Cham, Switzerland). Sheep were intubated and anaes-
thesia was maintained with 2% isoflurane (Pharmacia and
Upjohn AG, Dübendorf, Switzerland) in oxygen.
Each sheep was placed in right lateral recumbence and
the right tibia was prepared for aseptic surgery by routine
clipping and cleaning of the skin using a chlorhexidine
solution (Hibiscrub, Swissmedic, Bern, Switzerland). The
right tibia was draped routinely for a medial approach to
the tibial diaphysis. A 15 cm longitudinal incision centred
on the mid diaphysis was made through the skin
and subcutaneous tissues. Care was taken to avoid cut-
ting the periosteum. At the level of the mid diaphyses
(7 cm above the medial malleolus of the tibia) a length of
3 cm was marked on the bone. A seven hole, locking
CF - PEEK plate (snakeplate, Icotec AG, Altstätten,
Switzerland; Figure 1 and 2) was placed. Using the corre-
sponding drill sleeves, the first, second, sixth and seventh
holes were pre-drilled with a 4.0 mm drill bit. The third,
fourth and fifth holes were left empty as they were within
the defect zone. The plate was then removed and a 2.7
cm custom made spacer was placed and fixed with a
monocortical 3.5 mm screw in the centre of the marked,
pre-determined defect zone. Using an oscillating saw, the
full diameter of the tibia at the distal end of the spacer
was transected under constant cooling with Ringer’s solu-
tion (B. Braun Melsungen AG, Melsungen, Germany).
The tibia was then transected at the proximal end of the
spacer and the 3 cm defect created in removing of the
bone segment with the spacer attached. Care was taken
to ensure that all of the periosteum was removed and
that no tags of periosteum remained at the transected
bone ends. The snakeplate was then placed on the medial
aspect of the tibia again, the pre-drilled screw holes were
tapped and 4.5 mm CF - PEEK screws were placed.
A random selection of the screws contained tantalum
fibres that enabled them to be seen radiographically
(Figure 3A). The screws were tightened with a maximum
force of 1.5 Nm. Subsequently, a 7-hole, 4.5 mm locking
compression plate (LCP, Synthes GmbH, Oberdorf,
Switzerland) was contoured to the cranial aspect of the
Figure 1 Intra-operative situation after ostectomy and
osteosynthesis. The image shows the cranial LCP and the medial
snakeplate on the tibia. The ostectomy in the tibia is clearly visible
leaving space for potential tissue engineered solutions.
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were drilled using a 4.3 mm drill bit and self-tapping
5m ms c r e w s( S y n t h e sG m b H ,O b e r d o r f ,S w i t z e r l a n d )
were placed. Care was taken to ensure that the plates
were placed 90° to each other, that all screws were placed
bicortically, and that the screws did not interfere with
each other. This was done under visual control and
resulted in a 3 cm mid diaphyseal defect with the perios-
teum completely removed. The appropriate treatment
was placed into the defect and the fascia and subcutis
were closed with continuous sutures (Polyglecaprone 25,
Ethicon Inc., Neuchatel, Switzerland). The skin was
closed using skin staples.
Postoperative management and monitoring
Postoperative analgesia wasp r o v i d e db yi n t r a m u s c u l a r
(im) administration of carprofen (4 mg/kg BW, Rimadyl,
Pfizer AG, Zürich, Switzerland) and subcutaneous (sc)
injections of buprenorphine (0.01 mg/kg BW, Temgesic,
Reckitt and Colman Pharm., Hull, UK) at the end of sur-
gery. Additional analgesia was administered by means of
buprenorphine (0.01 mg/kg BW sc three times daily,
Temgesic, Reckitt and Colman Pharm., Hull, UK) for 3
days and carprofen (4 mg/kg BW im once daily, Rimadyl,
Pfizer AG, Zürich, Switzerland) for 5 days. No antimicro-
bial therapy was administered during or after aseptic sur-
gical procedures.
After surgery sheep were housed in single stalls. For
eight weeks post surgery the sheep were held in slings
(Figure 4) allowing them to stand, bear full weight on all
legs and move around in their boxes to a certain degree.
During this time the sheep were protected them from
high loading forces experienced when rising from a lying
down position. This handling concept was pre-planned
Figure 2 The two osteosynthetic plates used. Upper: 7 hole
broad LCP; lower: CF - PEEK (snakeplate) with the corresponding
screws.
Figure 3 Continuous radiographic evaluation in vivo. The latero-
medial radiographic image of the right tibia shows the situation
two weeks post operative (Figure 3A). The cranial LCP is clearly
visible while the medial snakeplate is radiolucent. The screws of the
snakeplate randomly include tantalum wires (note the white arrow
head) which make them visible on radiographs. If no tantalum wires
are included in the implant the screw is completely radiolucent
(image A, white arrow). On the radiographic image 24 weeks post
operative (Figure 3B) very little bone formation is visible. The
cortices alongside the ostectomy gap have narrowed and no
bridging has occurred. Even though in this case no load sharing
occurred there are no signs of implant loosening or instability. On a
radiographic image 24 weeks post operative evaluating a different
tissue engineered solution (Figure 3C) bridging has occurred. It was
possible to evaluate the amount of bone formation during the
study in one plane.
Figure 4 Animal supported by slings. A sheep on the second
day after surgery. The slings allow the sheep to fully weight bear
on the operated leg, but prevents peak loads during laying down
and standing up.
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approved by the Ethics Comission. The sheep were moni-
tored each day by an experienced animal caretaker and a
veterinarian for signs of inflammation, lameness and gen-
eral wellbeing. Here weight bearing and movement on
the operated limb were controlled visually. Two weeks
after surgery the skin staples were removed.
Lateromedial radiographs of the operated tibia were
taken immediately after surgery and every second week
(Figure 3). The radiographic examinations were per-
formed under sedation using detomidine (0,03 mg/kg
BW im, Domosedan, Pfizer AG, Zürich, Switzerland).
Bone regeneration was quantified using a digital image
software analysis programme (GIMP, GNU General Pub-
lic Licence). The results of the radiographic evaluation
are published elsewhere [13]. At the end of the study the
sheep were euthanized by means of an iv barbiturate
overdose (60 mg/kg BW, Pentobarbital, Eutha 77, Swiss-
medic, Bern, Switzerland). Time points of euthanasia
were at 3 month or 6 month after surgery, respectively,
depending on the original study question.
Results
There were no intraoperative complications during the
study. Surgical time was between 90 and 120 minutes.
Anaesthesia and recovery phase were uneventful for all
operated sheep. Twenty-four hours after surgery all
sheep were fully weight bearing on the operated limb. At
no time after surgery clinical signs of infection were
noticed. At about 2 weeks after surgery no clinical signs
of inflammation were detected with the incision wound
healed. The sheep adapted well to the slings and no com-
plications were associated with the use of the slings. The
animals were taken out of the slings at 8 weeks regardless
of the radiological state of healing within the defect.
Severe postoperative complications were experienced in
2 sheep. One sheep was euthanized one day after surgery
due to a fractured leg (Figure 5). The immediate post-
operative radiograph showed that the most distal screw in
the LCP was too short to engage both cortices (Figure 5).
At necropsy the distal screw had pulled out and a spiral
fracture extending through the two distal screw holes of
the LCP was diagnosed. A second sheep was euthanized
after 3 months because screw numbers 6 and 7 of the sna-
keplate were broken which resulted in increased loading
and subsequent bending of the LCP (Figure 5). The com-
plication rate was comparable in both groups with 1 sheep
in the 3 month and the 6 month group, respectively. Low
grades of lameness were noted in two sheep at 3 and 4
months after surgery. In these sheep the lameness was
localised to the front limbs and laminitis was suspected.
Based on this diagnosis, the sheep were placed on thick
straw bedding and the lameness resolved. No lameness or
pain was detected in any of the other sheep during the
whole study period. The overall incidence of severe com-
plications was 2 out of 33 sheep (6.1%).
Discussion
The successful treatment of large bone defects remains
extremely challenging. New treatment modalities such as
tissue engineered solutions are continuously being devel-
oped in order to expedite healing. Therefore, there is a
need for reliable critical sized bone defect models in ani-
mals that can test the efficacy of these solutions. Because
of the challenging nature of critical sized defects, many
animal models described in the literature report high mor-
bidity and high complication rates. For this reason we
have developed a model that reduces morbidity and com-
plications while enabling in vivo monitoring of bone
healing.
Animal models described in the literature vary consider-
ably, with differences in the species used, the defect size,
o s t e c t o m yl o c a t i o n ,s u r g i c a lt e c h n i q u ea n dt h et y p eo f
osteosynthesis used. The defect size is generally deter-
mined by the dimensions of the bone in which the defect
is made. In the sheep, a metatarsal defect of 0.6 cm consti-
tutes a critical sized defect [14] whereas in the tibia defects
of 3-4 cm are most common [10,11,15]. Unlike the femur
Figure 5 Radiographic evaluation of complications that have
occurred. Radiographic image of a sheep that had to be
euthanized 3 month after surgery (Figure 5D). Here both distal
screws of the snakeplate were broken and the LCP started to bend.
Radiographic image at the end of surgery (Figure 5E1), note screw
number 7 in the LCP is not placed bicortical (white arrow).
Radiographic image of the same sheep the day after surgery (Figure
5E2). At necropsy a spiral fracture extending through the 2 distal
screw holes of the LCP was diagnosed.
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due to large amounts of overlying musculature, and the
metatarsus which is limited in its vascularity due to scant
overlying musculature [14], the tibia is almost two-thirds
covered by muscle which provides excellent blood supply
while at the same time having an easily accessible medial
aspect which is devoid of muscle and major blood vessels.
Furthermore, there is approximately 9.5 cm of bone span-
ning the mid tibial diaphysis that is almost circular in
cross-section [3], making it particularly suitable for the
placement of scaffolds. Thus, the dimensions of the tibia
make it feasible to use either human or veterinary
implants for stabilisation of the defect.
Using the double plating technique, 6.1% of the sheep in
this study experienced severe complications necessitating
euthanasia. One sheep was euthanized due to a fractured
tibia the day after surgery. Post mortem evaluation
revealed that the surgical technique may have contributed
to failure in this case. The results, in which we had one
complication between 0 months and 3 months and one
complication between 3 months and 6 months, are com-
parable with the low complication rate reported by Den
Boer et al [11] following the use of an interlocking nail for
fixation of a 3 cm tibial defect for a period of 3 months.
Whereas, the overall complication rate of 6.1% in the pre-
sent study is more favourable than those experienced in
our own institute using a different sheep tibial defect
model [12]. It is difficult, however, to directly compare
complication rates of different studies because these often
show variability in defect size, study duration and type of
fixation. Interestingly, many of the studies which use the
sheep tibial defect have duration of less than 6 months. In
an earlier study in our own institute we performed a single
medial LCP osteosynthesis with a 4 cm mid tibial defect in
the sheep. In this study, fiveo f1 5( 3 3 % )a n i m a l so ft h e
experimental group did not reach the termination of the
study at 3, 6 and 10 month due to implant failure [12].
This highlights the value of the double plating technique
in providing maximum stability over a prolonged period
of time.
Other types of double fixation used for sheep tibial
defects have demonstrated higher complication rates than
the present study. Gao et al reported an 8.3% complication
rate following the use of a two-plate fixation technique for
a 1.6 cm tibial defect over a period of 4 months [16].
Krischak et al found that 2 out of 9 sheep in which a two-
plane external fixation was used experienced distal frac-
tures through the pin tracks [17]. This is a complication
rate of 22%. Also, 4 out of the 9 sheep experienced deep
infections; a complication that is commonly associated
with the long-term use of external fixation devices. In
the study by Krischack et al, healing of the osteotomy
was reduced when compared to a one-plane fixation [17].
The authors suggest that this might be due to greater
disturbance of the blood supply when using a two-plane
fixation [17]. Interference between the fixation device and
the blood supply and also with the implanted scaffold
must be taken into consideration when designing a sheep
critical sized defect study. The use of conventional
dynamic compression plates (DCPs) can result in impaired
blood supply to the bone due to compression of the peri-
osteum. In contrast, angular stable implants such as the
plates used in the present study, do not require direct con-
tact to the bone and do not compress the periosteum.
Consequently, the major blood supply to the bone is
preserved. Intramedullary nailing is another form of fixa-
tion [11,15] that results in complication rates that tend to
be quite low; however, there are several disadvantages to
this fixation method. Damage to the intramedullary blood
supply as a result of reaming may delay healing. To make
matters more complicated, the nail itself may affect bone
healing, such as in the case of titanium nails which are
known to have good osteoconductivity. The presence of
the nail, which occupies space within the centre of the
defect, limits the amount of test material that can be
implanted and also affects the shape of the scaffold mate-
rial in order to accommodate the centrally positioned nail.
Furthermore, the presence of the nail can interfere with
mechanical testing of the explanted bones and continuous
radiographic evaluation of bone formation is difficult. Two
plate constructs [16] often limit the ability for continuous
in vivo evaluation.
In the current study using a two-plate system, in which
one plate was radiolucent, continuous evaluation of bone
and callus formation was possible by taking latero-medial
radiographic images (Figure 3). This enables the researcher
to evaluate the amount of callus formation in different
experimental groups as well as the onset of callus forma-
tion. It has to be mentioned, however, that the snakeplate
can not be contoured and the maximal loading strength is
inferior to titanium alloy implants. This may have contrib-
uted to the failure of the distal screws in the second sheep
that had to be euthanized after 3 month.
The time frame up to 3 month was conducted to test
the biocompatibility of the tissue engineered solutions
since the occurrence of foreign body or inflammatory
reactions to the material is indicative for this phase. In the
time frame of 6 months, in previous studies dealing with
similar critical sized defects of the tibia we have not found
new bone formation after this time period. Most of the tis-
sue engineered constructs tested except calcium phos-
phates were resorbed and replaced by new bone within
this period. The rigid internal fixation using two angular
stable plates could well lead to a late onset of healing as
well as incomplete ossification due to load sharing situa-
tions between implants and bone. However, we believe
that minimizing micro motions is ideal for an animal
model because these micro motions account for bone
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present fixation method enables a reproducible rigidity in
this model.
In hind side, the use of the slings in this critical sized
defect model is questionable. After experiencing high com-
plication rates in critical sized defect models in large
animals in our own institute we have decided to accept the
additional reduction of life quality for the sheep in order to
lower the mortality significantly. All sheep were taken out
of the slings after 8 weeks regardless the stage of healing.
Even sheep that showed no or low degrees of bone healing
without additional stability did not show any complications
later on. However, it is possible, that micro fractures occur-
ring during surgery have healed by this time point.
Whether the use of the slings added significantly to the
low complication rate in this study is not applicable at this
time point and needs further investigation.
In total, 33 sheep were operated using this technique
with a low complication rate. The use of the radiolucent
snakeplate enabled continuous radiographic monitoring
which was beneficial for evaluating the healing response
over time.
Conclusions
We have found the described model to be a simple and
reproducible model for evaluating bone healing continu-
ously throughout the duration of the study. It results in
low morbidity and a low complication rate. Therefore, it is
sustainable for at least 6 months even when no load shar-
ing between implant and bone occurs. For these reasons
we believe that this model can be used as a standard
model for the evaluation of new tissue engineered solu-
tions for the treatment of large bone defects.
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